Speaker Profile
Alexander Drilon

Alexander Drilon MD

Internal Medicine, Medical Oncology
New York, New York, United States of America

Connect with the speaker?

Dr. Alexander Drilon is the Chief of the Early Drug Development Service and an Associate Attending Physician of the Thoracic Oncology Service at Memorial Sloan Kettering Cancer Center in New York. His research focuses on the development of targeted therapy for genomic subsets of lung cancer and other solid tumors, including cancers that harbor fusions involving ALK, ROS1, RET, NTRK1/2/3, and MET exon 14 skipping alterations. He is a recipient of the American Society for Clinical Oncology (ASCO)/Conquer Cancer Foundation Career Development and Young Investigator Awards and grants from the International Association for the Study of Lung Cancer and the Lung Cancer Research Foundation. Dr. Drilon is also a member of the Editorial Board of ASCO University.

EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)